EICHORPublic-registry site landscape for NCT04750902, “A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children”, a Dental Caries study sponsored by Colgate Palmolive. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04750902 (registry record) |
| Study title | A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children |
| Official title | A Phase 2 Randomized, Double-blind, Active-controlled Multi-center Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices With 1.5%, 4.0% and 8.0% Arginine Each in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children |
| Sponsor | Colgate Palmolive |
| Condition(s) | Dental Caries |
| Phase | PHASE2 |
| Listed sites | 9 |
| Intervention(s) | 0.24% Sodium Fluoride Dentifrice, 1.5% Arginine Dentifrice, 4.0% Arginine Dentifrice, 8.0% Arginine Dentifrice |
| Site countries | United States, Puerto Rico |
Patient-friendly overview of this study: eichor.com/study/NCT04750902.
Eichor generates a preliminary site-risk snapshot for NCT04750902 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
